FAP and neoplasm: We suspected that the longer blood retention could be caused by the increased lipophilicity of the ligands and potential interactions, such as π–π stacking between the quinoline ring and anthracene ring, which hindered the binding of tracers to FAP and PSMA, leading to decreased tumor uptake.